Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Genmab
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Atavistik Bio, Inc
M.D. Anderson Cancer Center
University of Miami
Natera, Inc.
National Institutes of Health Clinical Center (CC)
Seagen Inc.
University Health Network, Toronto
Washington University School of Medicine
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Taproot Health
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
Genmab
Kineta Inc.
Exact Sciences Corporation
Main Line Health
Imperial College London
Mary Crowley Medical Research Center
SpeciCare
Albert Einstein College of Medicine
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
Universidade Federal de Goias
University of Michigan
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Duke University
Memorial Sloan Kettering Cancer Center
Nova Scotia Health Authority
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center